BOSTON–(BUSINESS WIRE)–Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced financial results for the third quarter of 2023 and provided a general business update. “The third quarter was highlighted by our NDA submission…Read More
Karuna Therapeutics Reports Third Quarter 2023 Financial Results and Provides General Business Updates
